Manuscript Preparation and Submission Requirements for JOSMA
All manuscripts must be submitted to the Journal of the Oklahoma State Medical Association (JOSMA) to the managing editor Jeff Kelton. At the time of submission, complete contact information (affiliation, postal/mail address, e-mail address, telephone and fax numbers) for the corresponding author is required. First and last names, e-mail addresses, and institutional affiliations of all coauthors are also required. After the manuscript is submitted, the corresponding author will receive an acknowledgment confirming receipt and a manuscript number. After manuscript submission, all authors of papers under consideration for publication will be sent an Authorship Form to complete and submit .
Include a cover letter and complete contact information for the corresponding author (affiliation, postal/mail address, e-mail address, and telephone and fax numbers) and whether the authors have published or submitted any related papers from the same study
Manuscripts should be prepared in accordance with the AMA Manual of Style, 10th edition, 3and/or the Uniform Requirements for Manuscripts
Include a title page, abstract, text, references, and as appropriate, figure legends, tables, and figures. Start each of these sections on a new page, numbered consecutively, beginning with the title page.
Recommended File Sizes
We recommend individual file sizes of no more than 500 kB and not exceeding 1 MB, with the total size for all files not exceeding 5 MB
Manuscript File Formats
For submission and review, acceptable manuscript file formats include Word. Do not submit your manuscript in PDF format. Use 10-, 11-, or 12-point font size, double-space text, and leave right margins unjustified (ragged).
The title page should include a word count for text only (eg, not including abstract, acknowledgment, or references) and the full names, highest academic degrees, and affiliations of all authors. If an author’s affiliation has changed since the work was done, the new affiliation also should be listed.
Titles should be concise, specific, and informative and should contain the key points of the work.3 (p8) Please limit the length of titles 100 characters. For scientific manuscripts, overly general titles are not desirable and questions and declarative sentences should be avoided. For reports of clinical trials, meta-analyses, and systematic reviews, include the type of study as a subtitle (eg, A Randomized Clinical Trial, A Meta-analysis, A Systematic Review). For reports of other types of research, do not include study type or design in the title or subtitle.
Include a structured abstract of no more than 250 words for reports of original data, reviews, and meta-analyses. Abstracts should be prepared in JAMA style. Abstracts are not required for Editorials, Viewpoints, and some special features.
All reports of original data, systematic reviews, and meta-analyses should be submitted with structured abstracts.
Do not use abbreviations in the title or abstract and limit their use in the text. Define all abbreviations at first mention in the text.
Units of Measure
Laboratory values are expressed using conventional units of measure, with relevant Système International (SI) conversion factors expressed secondarily (in parentheses) only at first mention. Articles that contain numerous conversion factors may list them together in a paragraph at the end of the Methods section. In tables and figures, a conversion factor to SI should be presented in the footnote or legend. The metric system is preferred for the expression of length, area, mass, and volume. For more details, see the Units of Measure conversion table on the website for the AMA Manual of Style.
Methods and Human/Animal Rights Protection
Methods should be detailed enough to enable the study to be assessed for validity and trustworthiness. Please include a statement of approval by the appropriate human-subjects or animal-protection review boards, or an exemption/waiver.
Names of Drugs, Devices, and Other Products
Use nonproprietary names of drugs, devices, and other products, unless the specific trade name of a drug is essential to the discussion.
JOSMA does not republish text, tables, figures, or other material from other publishers, except under rare circumstances. Please delete any such material and replace with originals.
Authors are responsible for the accuracy and completeness of their references and for correct text citation. Number references in the order they appear in the text; do not alphabetize. In text, tables, and legends, identify references with superscript Arabic numerals. When listing references, follow AMA style and abbreviate names of journals according to the journals list in PubMed. List all authors and/or editors up to 6; if more than 6, list the first 3 followed by “et al.” Note: Journal references should include the issue number in parentheses after the volume number.
Examples of reference style:
1. Garbutt JM, Banister C, Spitznagel E, Piccirillo JF. Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA. 2012;307(7):685-692.
2. Steinbrook R, Ross JS. "Transparency reports" on industry payments to physicians and teaching hospitals [published online February 14, 2012]. JAMA. doi:10.1001/jama.2012.211.
3. Centers for Medicare & Medicaid Services. CMS proposals to implement certain disclosure provisions of the Affordable Care Act.http://www.cms.gov/apps/media/press/factsheet.asp?Counter=4221. Accessed January 30, 2012.
4. McPhee SJ, Winker MA, Rabow MW, Pantilat SZ, Markowitz AJ, eds. Care at the Close of Life: Evidence and Experience. New York, NY: McGraw Hill Medical; 2011.
Conflicts of Interest and Financial Disclosures
A conflict of interest may exist when an author (or the author’s institution or employer) has financial or personal relationships or affiliations that could influence (or bias) the author’s decisions, work, or manuscript. All authors are required to complete and submit a disclosure of potential conflict(s) of interest. Authors should also include conflict of interest disclosures in the Acknowledgment section of the submitted manuscript. Authors are expected to provide detailed information about all relevant financial interests, activities, relationships, and affiliations (other than those affiliations listed in the title page of the manuscript) including, but not limited to, employment, affiliation, funding and grants received or pending, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Authors without conflicts of interest, including relevant financial interests, activities, relationships, and affiliations, should indicate such on the disclosure form and include a statement of no such interests in the Acknowledgment section of the manuscript. Failure to include this information in the manuscript may delay evaluation and review of the manuscript. Authors should err on the side of full disclosure and should contact the editorial office if they have questions or concerns.
For all accepted manuscripts, the corresponding author will have been asked to confirm that each coauthor’s disclosures of conflicts of interest and relevant financial interests, activities, relationships, and affiliations and declarations of no such interests are accurate, up-to-date, and consistent with the disclosures reported in the Acknowledgment section of the manuscript because this information will be published in the Acknowledgment section of the article. The policy requiring disclosure of conflicts of interest applies for all manuscript submissions, including letters to the editor.
Editorial and Peer Review
All submitted manuscripts are reviewed initially by the JOSMA editor in chief. Manuscripts are evaluated according to the following criteria: material is original and timely, writing is clear, study methods are appropriate, data are valid, conclusions are reasonable and supported by the data, information is important, and topic has interest to the JOSMA readership. From these basic criteria, the editors assess a paper’s eligibility for publication. Manuscripts with insufficient priority for publication are rejected promptly. Other manuscripts are sent to consultants for peer review. Peer reviewer identities are kept confidential, but author identities are made known to reviewers. The
existence of a manuscript under review is not revealed to anyone other than peer reviewers and editorial staff. Peer reviewers are required to maintain confidentiality about the manuscripts they review and must not divulge any information about a specific manuscript or its content to any third party without prior permission from the journal editors. Identifying information remains confidential. Final decisions regarding manuscript publication are made by the editor in chief.